Dataset ID
NHA000074
- Type of data
- GWAS for HCC development after eradication of HCV by IFN-based treatment
123 patients who developed HCC
333 patients who did not develop HCC - Access criteria
- Unrestricted-access
- Total data volume
- 33.6 KB
- File formats
- XLSX
- Research
- hum0074
- Date published
- 2018-09-25
- Date modified
- 2018-09-25
- Secondary ID
- hum0074.v2.hcc.v1
Unrestricted-access files linked to this dataset
| File | Label | Size | Copy URL |
|---|---|---|---|
| hum0074.v2.hcc.v1.xlsx | 21.7 KB | ||
| hum0074.v2_ | Dictionary file | 11.9 KB |
Analysis method
Genotyping by array
- Materials and participants
- HCC development after eradication of HCV by IFN-based treatment (ICD10: C220)
123 patients who developed HCC
333 patients who did not develop HCC - Health statusAffected
- Subject count456 (Individual)
- Disease
- HCC development after eradication of HCV by IFN-based treatment (C220)
- Sample description
- gDNA extracted from peripheral blood cells
- TissuePeripheral blood
- Tumor / normalNormal
- Sample provider
- N/A
- Experimental method
- Genotyping by array
- Target
- N/A
- Reagent kit
- Axiom 2.0 Reagent Kit
- Platform
- DigiTag2 assay
TaqMan SNP Genotyping Assays
Affymetrix Axiom Genome-Wide ASI 1 Array - Reference genome
- NCBI36
- QC and filtering
- Sample call rate < 0.95, SNP call rate < 0.95, MAF < 0.05,
HWE P < 0.001, Chi-square test (allelic model) P < 1 x 10^-4 - Analysis method
- Genotyping Console v4.1
- Variant count
- 70 SNPs
- Data use policy
- NBDC data sharing policy (JGAP000001)